Evaluate the expected performance of Teladoc (TDOC) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
The latest trading day saw Teladoc (TDOC) settling at $5.7, representing a -3.72% change from its previous close.
Teladoc (TDOC) closed the most recent trading day at $5.69, moving 2.23% from the previous trading session.
Teladoc Health is transitioning from a cyclical D2C model to a higher-margin, data-driven B2B platform, supporting a Buy rating at low multiples. TDOC's BetterHelp segment is pivoting to insurance reimbursement, aiming for $75–90M in 2026 insurance revenue, reducing churn and acquisition costs. Integrated Care leverages PulseAI and proprietary datasets to deliver predictive, high-ROI services to employers and health plans, supporting premium pricing and margin expansion.
TDOC trades at a discount as Teladoc expands AI-driven care, cuts costs, and eyes better profitability, but BetterHelp weakness and rising competition cloud outlook.
Teladoc (TDOC) reached $5.28 at the closing of the latest trading day, reflecting a -3.12% change compared to its last close.
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
In the latest trading session, Teladoc (TDOC) closed at $5.42, marking a -1.09% move from the previous day.
In the latest trading session, Teladoc (TDOC) closed at $5.47, marking a -1.8% move from the previous day.
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Teladoc Health, Inc. (TDOC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
TDOC posts narrower-than-expected Q4 loss, topping revenue estimates as international and Integrated Care strength offset BetterHelp weakness.